DiabetOmics, Inc., a medical diagnostics company, engages in the non-invasive assessment and management of personalized health and diabetes risk, progression, and complications. The company offers several tests and profiles for diabetes and diabetes complications. Tests target individuals with preecleampsia, gestational diabetes, and individuals with diabetes and autoimmune disorders, providing critical information that allows doctors to diagnosis, treat, and follup more effectively. In addition, the company engages in research and development in the areas such as Proteomics and Dried Blood Spot Technologies.
